Products /Processes Under Development Through BIPP Support Company/Collaborator(s) S. No.

Product/Process Description Name Health Care/Drugs/Vaccines Torrent Pharmaceuticals 1. Drug for Diabetes associated Heart Failure Limited Anti- TNF-alpha Antibody scFv for treatment of 2. ARA Healthcare Limited Inflammatory Diseases Process for Asymmetric Synthesis of 3. TCG Life Sciences Limited Hexahydrobenzophenanthrenes, Dopamine D1 Agonists Technology development for implant based sustained release Bharat Serums and Vaccines 4. formulations incorporating therapeutic peptides/ recombinant Limited proteins (i) Amrita Therapeutics Limited Identification and Development of Promiscuous Anticancer (ii) National Institute of 5. Compounds from Microorganisms Immunology, New Delhi
(iii) B.V. Patel PERD Centre, Ahmedabad

6.

7. 8. 9. 10.

11.

Development of animal component free biosimilar Wockhardt Limited recombinant protein therapeutics using mammalian platform technology Lifecare Innovations Pvt. Ltd Production of poly (lactide-co-glycolide) nanoparticles ( PLGNP )and poly (lactide-co-glycolide) nanoparticles encapsulating antitubercular drugs (rifampicin, isoniazid and pyrazinamide- PLG-NP-ATDs) in GMP facilities Virchow Biotech Private Ltd Mucosal Vaccine For HPV Gennova Biopharmaceuticals Recombinant Human Papillomavirus vaccine Limited Gennova Biopharmaceuticals Bio-similar interferon beta 1a: process development Limited (i) Serum Institute of India Limited (ii) Indian Institute of Science, Immunogens and monoclonal antibodies against pandemic H1N1 Bangalore
(iii) National Institute of Immunology, New Delhi

12. 13.

Serum Institute of India Limited (i) RAS Life Sciences

Clinical Development of Polysialylated Erythropoietin

Development of HCV genotype 3a based replicon system (ii) Institute of Liver and Billiary Sciences, New Delhi Bigtec Private Limited Health Care/Diagnostics Point-of-Care detection of infectious disease using handheld
1

14.

microPCR 15. Amar Immunodiagnostics Pvt. Immunodiagnostic kits for detection of autoimmune diseases Ltd. Health Care/Clinical Trial (i) Bharat Biotech International Limited
(ii) Christian Medical College, Vellore (iii) KEM Hospital Research Centre, Pune (iv) Translational Health Science and Technology Institute, New Delhi

16.

Rotavirus Vaccine Candidate 116E

17. 18. 19.

Torrent Pharmaceuticals Limited Panacea Biotec Limited V-Life Sciences Technology Pvt. Ltd. Biological E Limited.

20.

21.

Biocon Limited

22. 23. 1. 2. 3. 4. 5.

Perfint Healthcare Pvt. Ltd. Frontier Lifeline Private Limited Maharashtra Hybrid Seeds Company Limited Metahelix Life Sciences Private Limited Maharashtra Hybrid Seeds Company Limited Advanta India Limited (i) Advanta India Limited

Clinical development of TRC150094, a novel Diiodothyronine (T2) analogue, for the treatment of cardiovascular (CV) risk factors defined by Metabolic Syndrome (MS). H1N1 pandemic influenza vaccine Clinical Investigation of Galnobax for the treatment of Diabetic foot Ulcers A Multicentric, Parallel Randomised (2:1) Open Label Phase III Clinical Study To Evaluate The Immunogenicity And Safety Of BE Inactivated JE Vaccine In Healthy 1 To <3 s Year Old Indian Subjects In Comparison With Purified Inactivated JE Vaccine (IXIARO) Of Intercell An NonInferiority Study A Multicenter, Randomized, Double-Blind, Placebo Control Study of IN-105 tablets [oral insulin] in Patients with Type 2 Diabetes Mellitus who have inadequate Glycemic Control on Optimal doses of Extended Release Metformin Tablets. Health Care Solution for planning, execution and confirmation of targeted ablation therapy Porcine Pulmonary Xenograft as a Conduit in Cardiovascular Surgery Agriculture Stress tolerant rice Transgenic rice tolerant to rice yellow stem borer Sucking Insect Pest tolerant rice and cotton Drought and multiple diseases & pests tolerant rice through Multi stacking genes RNAi and other cuting edge technological interventions to
2

(ii) Indian Agriculture Research develop insect-pest diseases & viruses tolerant tomato hybrids Institute, New Delhi for Indian & International markets

6.

(i) Bejo Sheetal Seeds Private Limited

(ii) International Centre for Genetic Engineering and Biotechnology , New Delhi

Herbicide & Stress tolerant transgenic Onion Control of Shoot and Fruit Borer Insect Pest (Leucinodes orbonalis Guene) in Brinjal Through RNA interference Deregulation Trials Phase I of Transgenic Maize Events Expressing Metahelix Synthetic Cry1C, Cry1Ac and Cry1Ab Genes for Tolerance to Stem and Cob Borers To conduct confined field trials and biosafety studies on genetically engineered Brassica juncea (Male sterility and restorer lines as pollination control mechanism) for heterosis breeding and yield improvement Inorganic and polymer nano-composites for micronutrient & pesticide delivery: Boosting crop health and yield.

7.

8.

(i) Sri Biotech Laboratories India Ltd. (ii) University of Delhi South Campus Metahelix Life Sciences Private Limited Mother Dairy Fruit and Vegetable Private Limited Tata Chemicals Limited

9.

10.

11.

(i) Nirmal Seeds Pvt. Ltd. Development of nutritionally improved mustard (Brassica (ii) The Energy and Resources juncea) varieties/hybrids having low erucic acid and low Institute, New Delhi glucosinolate content using marker assisted selection Avesthagen Limited Richcore Lifesciences Pvt Ltd. Nagarjuna Fertilizers and Chemical Limited (i) Bharat Petroleum Corporation Limited (ii) The Energy and Resources institute, New Delhi Thermax Limited India Glycols Limited SPC Biotech Energy Self-glucogenic Pearl Millet for Bio-ethanol products A process for Enhanced Ethanol Yield from Molasses Fermentation Biological Hydrogen Production Butanol production from lignocellulosic biomass Anaerobic Membrane Bioreactor (AnMBR) for Waste to Energy Solutions Setting up a 10 ton Lignocellulosic biomass/day processing plant to produce about 3000 Litre ethanol/day Bioconversion of Agricultural Waste from Mango kernel, to Polylactic acid a bio-plastic

1. 2. 3. 4. 5. 6. 7.

1.

Capacity Building through Infrastructure Support Span Diagnostics Limited Establishment of cGMP compliant Bioprocess Facility for large-scale production of Microbial antigens and Monoclonal
3

2.

Intas Biopharmaceuticals Private Limited

antibodies Facility for high end structural and functional characterization of protein therapeutics and peptides